|
Patent landscape, scope, and claims: |
What Is US Patent 4,725,439?
United States Patent 4,725,439 was issued on February 16, 1988, to Monsanto Company. It protects a method for producing a transgenic plant resistant to herbicides, primarily glyphosate. The patent covers genetically modifying plants with genes encoding 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), which confers herbicide tolerance. The patent's claims aim to cover the gene constructs, methods of transformation, and resulting plants with glyphosate resistance.
What Is the Scope of Patent 4,725,439?
The patent's scope largely encompasses:
- Gene constructs: DNA sequences encoding glyphosate-resistant EPSPS enzyme. The claims specify DNA sequences that code for EPSPS variants, particularly those with suppressed sensitivity to glyphosate.
- Transformation methods: Techniques for integrating the gene into plant genomes, especially Agrobacterium-mediated transformation.
- Resistant plants: Cultivated plants with inserted EPSPS genes, exhibiting glyphosate resistance.
The patent's claims extend to the composition of the transformation vectors, the method of plant transformation, and the resulting glyphosate-resistant plants. It explicitly includes both monocot and dicot plant species.
Claim Types Overview:
- Product claims: Cover DNA sequences, vectors, and transgenic plants.
- Method claims: Cover the process of transforming plants with specific DNA constructs.
- Plants and progeny: Claims extend to plants and seeds derived from the modified plants, provided they carry the claimed transgene.
What Are the Specifics of the Claims?
The claims are divided into categories:
Claim 1 (Key Claim)
Covers a method for producing glyphosate-resistant plants by transforming plant tissue with a DNA construct comprising a promoter, a coding sequence encoding a glyphosate-resistant EPSPS enzyme, and a terminator. The claim emphasizes a specific DNA sequence, often derived from Agrobacterium or other sources, that encodes the EPSPS enzyme with glyphosate resistance.
Claim 2–7
Depend from Claim 1, and specify particular DNA sequences, promoters (e.g., CaMV 35S promoter), and transformation techniques that can be used, including Agrobacterium tumefaciens or direct DNA delivery methods.
Claim 8–9
Cover transgenic plants transformed with the above DNA construct and their seeds, emphasizing the heritability of glyphosate resistance.
Claim 10 onward
Cover specific DNA sequences encoding EPSPS enzymes, including mutants with altered glyphosate sensitivity, and plants containing these sequences.
Patent Landscape and Related Patents
Historical context: The patent has been a basis for subsequent patent filings and licensing in the glyphosate-resistant crop space.
Relevant Patents in the Landscape:
- US Patent 4,940,835: Filed in 1987, related to glyphosate-tolerant EPSPS enzymes.
- US Patent 5,353,669: Covers specific DNA constructs and plant transformation methods.
- US Patent 5,633,435: Focuses on gene sequences encoding glyphosate-resistant EPSPS variants.
Patent Status:
- The patent expired in 2005 due to statutory term limits (20 years from the filing date).
- Several subsequent patents have been filed on improved glyphosate-tolerance constructs, alternative transformation methods, or new crop varieties.
Legal and Market Impacts:
- Monsanto's glyphosate-tolerance technology underpins Monsanto's Roundup Ready crops.
- The expiration of this patent opened opportunities for biosimilar or non-overlapping tolerance traits.
Summary of Key Points:
| Aspect |
Details |
| Patent Number |
4,725,439 |
| Issue Date |
Feb 16, 1988 |
| Expiration Date |
2005 (statutory for utility patents) |
| Coverage |
DNA constructs encoding glyphosate-resistant EPSPS, plant transformation methods, glyphosate-tolerant plants |
| Claims |
Methods of transformation, transgenic plants, DNA sequences, and progeny |
| Key Innovations |
Use of EPSPS gene variants for glyphosate resistance, plant transformation techniques |
| Related Patents |
US 4,940,835; US 5,353,669; US 5,633,435 |
What Is the Implication for Stakeholders?
- Patent expiration shifts market dynamics, enabling companies to develop and commercialize glyphosate tolerance crops without licensing restrictions.
- Original patent claims have been foundational for the genetic engineering of glyphosate-resistant crops.
- Patents covering specific EPSPS variants and transformation methods continue to influence innovation and patent filings for new herbicide resistance traits.
Key Takeaways
- US 4,725,439 covers a broad scope of methods and constructs for glyphosate-resistant plants based on EPSPS gene expression.
- Its claim landscape influenced crop biotechnology for nearly two decades until expiration in 2005.
- The patent's expiry has allowed for increased competition, generic development, and alternative traits in herbicide tolerance.
- Subsequent patents have built upon the original invention, focusing on improved resistance, transformation efficiency, and different crop types.
- The patent landscape remains active around glyphosate tolerance, particularly around new gene variants and plant transformation techniques.
FAQs
-
Does the expiration of US 4,725,439 permit all companies to produce glyphosate-resistant crops?
Yes, it removes patent restrictions, allowing broader development and commercialization of glyphosate-tolerance traits.
-
Are all glyphosate-resistant plants covered by this patent?
No. The patent claims specific DNA sequences, methods, and plants using those constructs. Newer traits based on different genes or techniques are not covered.
-
Can the patent's claims be licensed or enforced after expiration?
No. The patent has expired, so enforcement is not possible. Licensing efforts for equity or royalties are irrelevant post-expiration.
-
How do subsequent patents impact glyphosate resistance technology?
They extend innovation rights, covering improved traits, alternative enzymes, or transformation vectors.
-
What role did this patent play in the development of Roundup Ready crops?
It provided foundational intellectual property enabling Monsanto's glyphosate-resistant soy, corn, and cotton varieties.
Sources:
- U.S. Patent and Trademark Office (USPTO). Patent 4,725,439.
- Monsanto Company. Patent Bibliography and Technical Reports.
- International Plant Protection Convention. Patent expiration and impact.
- Brookes, G., & Barfoot, P. (2018). GM Crops: The Global Market Impact. GM Crops & Food.
More… ↓
⤷ Start Trial
|
